US Organ Preservation Market size was valued at USD 72.00 Mn. in 2024 and the total US Organ Preservation revenue is expected to grow at a CAGR of 3.9% from 2025 to 2032, reaching nearly USD 97.78 Mn.

Market Estimation with Growth Drivers & Opportunities
The US Organ Preservation Market was valued at approximately USD 72 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.9 %, reaching nearly USD 97.8 million by 2032. This steady growth is attributed to several key factors.

First, the rising prevalence of chronic diseases—especially kidney and liver conditions—has significantly increased the demand for organ transplants. An aging population and an increase in end-stage organ failures have further driven the need for effective preservation methods. Second, advancements in preservation techniques, such as hypothermic and normothermic machine perfusion, are enhancing organ viability and transplant success rates. Third, improved logistics and transport systems, including AI-enabled tracking and smart cold-storage containers, are reducing organ loss during transit.

Major opportunities include the integration of smart monitoring systems within organ preservation devices, development of next-generation preservation solutions such as gene-silencing preservation fluids, and greater investment in R&D partnerships between hospitals, universities, and private firms. As public awareness of organ donation increases and regulations continue to support donor programs, the market outlook remains positive.

Access your sample copy of this report right now! https://www.stellarmr.com/report/req_sample/US-Organ-Preservation-Market/1642

US Market: Latest Trends & Investment (2024–2025)
In 2024 and into 2025, the US market has seen major shifts in investment and innovation. Notably, a UK-based organ preservation technology company secured USD 142 million in funding to expand its presence in the US. The company’s flagship perfusion system—used for preserving livers beyond the traditional cold-storage window—has gained traction across leading US transplant centers. The investment is also being used to support the development of a similar platform for kidney preservation, indicating expansion into new organ segments.

This reflects a broader trend toward normothermic ex-vivo perfusion, which mimics the body's internal environment and allows for real-time monitoring and assessment of organ function before transplantation. Additionally, transplant centers in the US are increasingly partnering with logistics firms and AI companies to enhance the efficiency of organ transport systems, reduce wastage, and comply with tighter federal transportation guidelines.

Segmentation: Largest Share
Within the market, the Deceased Organ Donation segment held the largest share at around 30 % in 2024. This segment continues to dominate due to the volume of available donors and the development of advanced preservation methods that help reduce organ deterioration post-mortem.

Deceased donations also benefit most from innovations in long-duration preservation solutions and organ perfusion technologies. These innovations are critical in maximizing the usable window for organs retrieved from deceased donors, especially for transplants requiring cross-country or international transport.

Competitive Analysis: Top 5 Global Players
The organ preservation market is led by a few key global players who are driving growth through innovation, acquisitions, and strategic investment:

Paragonix Technologies, Inc. – A US-based company known for its advanced organ transport systems. In 2024, it was acquired by a major European medical device firm for approximately USD 477 million, enhancing its global reach and product development pipeline.

OrganOx Ltd. – This UK-based company has introduced a device that extends liver viability outside the body for up to 24 hours using normothermic perfusion. It has been widely adopted in the US and is undergoing trials for kidney applications, backed by significant new capital investment in 2025.

XVIVO Perfusion AB – A Sweden-based firm, XVIVO specializes in perfusion systems for lungs and is expanding into liver and kidney applications. The company is investing heavily in next-generation devices that offer temperature regulation and real-time performance analytics.

Dr. Franz Köhler Chemie GmbH – Based in Germany, this company produces Custodiol HTK solution, one of the most widely used organ preservation fluids globally. Its strong distribution network and research in enhanced formulations keep it at the forefront of the preservation media segment.

Essential Pharmaceuticals LLC – This US-based firm produces the University of Wisconsin (UW) solution, which holds over 45 % market share in the global preservation media segment. The company is continuously optimizing its solutions for better efficacy across a range of organs, including pancreas and intestines.

These companies are making major investments in longer preservation times, broader organ applications, and data-integrated devices that give surgeons real-time feedback about organ condition during transport. Strategic mergers and product expansion into kidney and lung preservation will likely drive market consolidation and innovation in the coming years.

For additional resources and details on this research, check out: https://www.stellarmr.com/report/US-Organ-Preservation-Market/1642

Regional Analysis: USA, UK, Germany, France, Japan, China

USA: The United States commands approximately 36–45 % of the global organ preservation market, fueled by high transplant volumes, FDA support for perfusion device approvals, and ongoing public-private investments in transplant infrastructure. Organizations are working closely with federal agencies to improve transplant logistics and reduce discard rates, which currently stand at nearly 20% for some organs.

UK: With several pioneering preservation companies and strong government support for biomedical innovation, the UK plays a crucial role in the global ecosystem. Companies are actively exporting preservation technologies to the US and EU, and NHS continues to fund R&D programs to extend organ preservation times.

Germany: Germany’s prominence stems from its leadership in cold-storage media production and adoption of perfusion systems in national transplant centers. The country has robust reimbursement policies and strong public education around organ donation, driving consistent growth.

France: The French market benefits from a highly organized public health system and increased use of machine perfusion in transplant hospitals. National policies encourage innovation and donor awareness, contributing to growth in both domestic and regional markets.

Japan: Japan has made significant strides in transplant adoption through regulatory modernization and donor awareness campaigns. Hospitals are investing in cold-preservation solutions and early-stage normothermic perfusion systems.

China: With rapid infrastructure development and government-backed deceased donor programs, China is one of the fastest-growing markets for organ preservation. Investments in local device manufacturing and training of transplant professionals are key drivers.

Discover What's Trending :

Orthopedic Trauma Fixation Devices Market https://www.stellarmr.com/report/Orthopedic-Trauma-Fixation-Devices-Market/1792

Respiratory and Anaesthesia Disposable Market https://www.stellarmr.com/report/respiratory-and-anaesthesia-disposable-market/2715

Conclusion & Outlook
The US organ preservation market is on a steady upward trajectory, backed by clinical demand, innovation, and expanding investment. While cold-storage preservation still dominates, the future clearly lies in dynamic perfusion systems, AI-integrated transport logistics, and new-generation preservation solutions that can extend viability across organ types and distances.

Key growth opportunities include:

Broader adoption of machine perfusion devices beyond liver to kidney, lung, and heart transplants.

Expansion of public–private partnerships that lower organ discard rates.

Continued investment in organ preservation R&D, especially in smart fluids and remote monitoring capabilities.

Emerging digital solutions for organ tracking and data-sharing across transplant networks.

In conclusion, organ preservation is no longer a behind-the-scenes function but a core driver of success in transplant medicine. As innovation continues to bridge science and logistics, the market is expected to play an increasingly central role in saving lives.

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Stellar Market Research:

S.no.8, h.no. 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud, Pune,

Pune, Maharashtra, 411029

[email protected]

+91 20 6630 3320, +91 9607365656